Here is what you need to know on Wednesday, January 19:
Bond yields continue to surge as the German 10-year yield hits a near three-year high. German yields are in positive territory for the first time since May 2019. US yields are also on the move, albeit the rise has slowed slightly today. Morgan Stanley (MS) and Bank of America (BAC) may have put an end to recent bank weakness with some impressive results. However, Morgan Stanley is down in premarket after missing on revenue. Bank of America also missed on revenue, but the shares are ahead by 3% currently on a strong profit number. The large profit was helped by reserve releases, the very excuse that was used to punish Citi (C) shares last week. Go figure!
The dollar is moderately weaker at 1.1350 versus the euro. The European Central Bank (ECB) faces a showdown with the bond market, and investors begin pricing in a rate hike this year despite the ECB saying no way. Bitcoin is flat at $42,300, and Gold is at $1,819. Oil is strong at $86 as IEA says demand to strengthen.
European markets are higher: Eurostoxx +0.85, FTSE +0.5% and Dax +0.5%.
US futures are also higher: S&P +0.4%, Dow +0.2% and Nasdaq +0.6%.
Wall Street (QQQ) (SPY) Stock News
IEA says oil demand to reach pre-pandemic levels this year.
UK inflation surges again to a 30-year high of 5.4% versus the 5.2% estimate.
Morgan Stanley (MS) beats on EPS but misses on revenue.
Bank of America (BAC) beats on EPS but misses on revenue.
Proctor & Gamble (PG) beats on revenue and EPS.
SOFI shares up 18% on regulatory approval to become a bank through acquisition.
United Health Group (UNH) beats on EPS and revenue.
Tegna (TGNA) to be bought out by private equity, according to The New York Post.
AT&T (T) and Verizon (VZ) delay implementation of 5G near airports.
Mastercard (MA) makes a deal on NFT payments with Coinbase (COIN).
Pfizer (PFE) says studies show its covid pill works against Omicron.
Bath&Body Works (BBWI) added to Goldman's conviction buy list.
Lucid Group (LCID): some early-stage investors are out of PIPE lockup today.
Upgrades and Downgrades
Source: Benzinga Pro
Economic releases
Like this article? Help us with some feedback by answering this survey:
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD extends gains above 1.0700, focus on key US data
EUR/USD meets fresh demand and rises toward 1.0750 in the European session on Thursday. Renewed US Dollar weakness offsets the risk-off market environment, supporting the pair ahead of the key US GDP and PCE inflation data.
USD/JPY keeps pushing higher, eyes 156.00 ahead of US GDP data
USD/JPY keeps breaking into its highest chart territory since June of 1990 early Thursday, recapturing 155.50 for the first time in 34 years as the Japanese Yen remains vulnerable, despite looming intervention risks. The focus shifts to Thursday's US GDP report and the BoJ decision on Friday.
Gold price edges higher amid weaker USD and softer risk tone, focus remains on US GDP
Gold price (XAU/USD) attracts some dip-buying in the vicinity of the $2,300 mark on Thursday and for now, seems to have snapped a three-day losing streak, though the upside potential seems limited.
Injective price weakness persists despite over 5.9 million INJ tokens burned
Injective price is trading with a bearish bias, stuck in the lower section of the market range. The bearish outlook abounds despite the network's deflationary efforts to pump the price.
US Q1 GDP Preview: Economic growth set to remain firm in, albeit easing from Q4
The United States Gross Domestic Product (GDP) is seen expanding at an annualized rate of 2.5% in Q1. The current resilience of the US economy bolsters the case for a soft landing.